GKB Ophthalmics swings to profit as consolidated revenue jumps
The company posted a consolidated net profit of ₹3.03 crore for FY26, reversing a prior-year loss of ₹7.08 crore on the back of rising sales.
— 2 earlier stories on GKB Ophthalmics Ltd. →What's new
- Consolidated revenue climbed to ₹149.06 crore from ₹108.99 crore in the prior year.
- Standalone net loss narrowed to ₹3.57 crore from ₹6.11 crore.
- K.G. Gupta reappointed as chairman and managing director for three years.
Why this matters
The swing to consolidated profitability is a significant shift for a company with a market cap of only ₹34 crore. However, the absence of a dividend and the persistent standalone loss suggest the underlying business remains under financial pressure.
What we're watching
- Whether the consolidated profit trajectory can be sustained in FY27.
- Any signs of improvement in standalone operational efficiency.
- Future board decisions regarding dividend payouts.
The full read
GKB Ophthalmics returned to the black on a consolidated basis for FY26, reporting a net profit of ₹3.03 crore against a loss of ₹7.08 crore the year prior. This turnaround follows a jump in consolidated revenue to ₹149.06 crore from ₹108.99 crore. Despite the consolidated improvement, the company's standalone performance remains strained, with a net loss of ₹3.57 crore—though this is an improvement over the ₹6.11 crore loss recorded in the previous year. The board opted against a dividend for the year, reflecting the ongoing financial constraints facing the ₹34 crore market-cap firm. Leadership remains steady, with K.G. Gupta reappointed as chairman and managing director for a three-year term starting in April 2027. The company has successfully grown its top line, but the gap between consolidated gains and standalone losses remains the primary test for the coming year.
Questions answered
- How did GKB Ophthalmics' consolidated performance change year-over-year?
- The company moved from a consolidated net loss of ₹7.08 crore in the previous year to a net profit of ₹3.03 crore for the year ended March 2026.
- What drove the consolidated profit turnaround?
- The profit was driven by a sharp increase in revenue from operations, which rose to ₹149.06 crore from ₹108.99 crore.
- Did the board declare a dividend?
- No, the board did not recommend a dividend for the year.
- What changes occurred at the leadership level?
- The board reappointed K.G. Gupta as chairman and managing director for a three-year term beginning in April 2027.
- How did the standalone results compare to the consolidated figures?
- While the consolidated business turned profitable, the standalone entity continued to report a loss, though it narrowed to ₹3.57 crore from ₹6.11 crore.
Story so far
All notes on GKB →- 27 May 2026 · 8:17 PM IST GKB Ophthalmics swings to profit as consolidated revenue jumps
- today GKB Ophthalmics swings to profit after liquidating subsidiary
- today GKB Ophthalmics is in default on ₹15.1 cr of bank debt